Bill.com (BILL) Rises 15% On Narrower Loss, 'Transformative' Divvy Acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Bill.com Holdings Inc. (BILL) PT Raised to $195 at Wolfe Research
May 7, 2021 9:33 AM EDTWolfe Research analyst Darrin Peller raised the price target on Bill.com Holdings Inc. (NYSE: BILL) to $195.00 (from $185.00) while maintaining a Outperform rating.... More
Bill.com Holdings Inc. (BILL) PT Raised to $180 at Piper Sandler
May 7, 2021 9:32 AM EDTPiper Sandler analyst Brent Bracelin raised the price target on Bill.com Holdings Inc. (NYSE: BILL) to $180.00 (from $170.00) while maintaining a Overweight rating.... More
Pre-Open Stock Movers 05/07: (IBIO) (BILL) (AXON) Higher; (CCIX) (APPN) (FROG) Lower (more...)
May 7, 2021 9:20 AM EDTPre-Open Stock Movers
ChemoCentryx, Inc., (Nasdaq: CCXI) 55.8% LOWER; mixed vote from FDA Arthritis Advisory Committee on avacopan for the treatment of Antineutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis (or AAV). Multiple analyst downgrades.
iBio, Inc. (NYSE: IBIO) 43% HIGHER; provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.
Bill.com (NYSE:... More
Bill.com Holdings Inc. (BILL) PT Raised to $175 at KeyBanc
May 7, 2021 4:56 AM EDTKeyBanc analyst Josh Beck raised the price target on Bill.com Holdings Inc. (NYSE: BILL) to $175.00 (from $165.00) while maintaining a Overweight rating.... More
After-Hours Stock Movers 05/06: (IBIO) (BILL) (AXON) Higher; (APPN) (STMP) (FROG) Lower (more...)
May 6, 2021 6:08 PM EDTAfter-Hours Stock Movers
iBio, Inc. (NYSE: IBIO) 43% HIGHER; provided an update on its IBIO-201 program and reported on its progress in developing a second-generation subunit vaccine candidate, IBIO-202, being designed for the prevention of SARS-CoV-2 infection.
Bill.com (NYSE: BILL) 15% HIGHER; reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $54.6 million. Entered into a definitive agreement to acquire Divvy in a stock and cash transaction valued at... More
Bill.com (BILL) to Acquire Divvy for $2.5B
May 6, 2021 4:12 PM EDTBill.com (NYSE: BILL) announced it has entered into a definitive agreement to acquire Divvy in a stock and cash transaction valued at approximately $2.5 billion. Divvy is a leader in spend management that modernizes finance for business by combining expense management software and smart corporate cards into a single platform.
The acquisition supports Bill.coms mission and enhances our ability to deliver value to the combined customer base. Bill.coms expanded solution will enable businesses to automatically manage accounts payable, accounts receivable, and corporate card spend all in one place,... More
Bill.com (BILL) Tops Q3 EPS by 5c
May 6, 2021 4:11 PM EDTBill.com (NYSE: BILL) reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $54.6 million.
GUIDANCE:
Bill.com sees Q4 2021 EPS of ($0.05)-($0.04), versus the consensus of... More
